サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1751518

動物医療向けモノクローナル抗体の市場規模、シェア、動向分析レポート：用途別、動物タイプ別、エンドユーザー別、地域別、セグメント予測、2025年～2030年

Monoclonal Antibodies In Veterinary Health Market Size, Share & Trends Analysis Report By Application (Dermatology, Pain), By Animal Type (Dogs), By End User (Veterinary Hospitals), By Region, And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 150 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.72円
動物医療向けモノクローナル抗体の市場規模、シェア、動向分析レポート：用途別、動物タイプ別、エンドユーザー別、地域別、セグメント予測、2025年～2030年
出版日: 2025年05月29日
発行: Grand View Research
ページ情報: 英文 150 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

動物医療向けモノクローナル抗体市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、動物医療向けモノクローナル抗体の世界市場規模は、2025年から2030年にかけてCAGR 19.1%で拡大し、2030年には33億米ドルに達すると推定されています。

ペット数の増加とペット支出の増加が相まって、市場成長を押し上げると予想されています。さらに、犬アトピー性皮膚炎の有病率の増加は、予測期間中の市場成長を促進する可能性が高いです。

COVID-19パンデミックによる混乱にもかかわらず、動物用医薬品業界は2019年から2020年にかけて8%の安定成長を示しました。経済不況は、他の市場に比べて動物用医薬品業界では比較的影響が少なかったです。パンデミックは、動物病院と獣医師のビジネスモデルにいくつかの変化をもたらしました。従来の動物病院は、生物製剤や医薬品のような利益率の高い製品の販売から最も多くの収益を上げると予想されます。

特に犬におけるがんの増加は、市場に成長基盤を提供すると予想されます。米国獣医師会（AVMA）によると、犬の4頭に1頭は、生涯のある時点で新形成の兆候を示すと予想されています。新形成は犬によく見られるがんの一種です。疼痛管理は、犬の新形成の治療において最も重要な側面のひとつです。これはモノクローナル抗体による治療も可能です。

市場は競争が激しく、複数の大手企業が参入しています。市場に巨大な機会が出現したことで、市場の様々な企業がリーディング企業として台頭するために投資を行っています。例えば、2021年10月、Zoetis社は動物用モノクローナル抗体（mAbs）の生産能力を向上させるため、アイルランドに新たな開発製造ユニットを取得しました。

これにより、動物用治療バイオ医薬品のポートフォリオが強化されると予想されます。さらに2021年8月、エランコはキンドレッド・バイオサイエンシズを約4億4,400万米ドルで買収しました。これによりエランコは皮膚科市場への参入を支援し、製品パイプラインを補完し、生物製剤とモノクローナル抗体の研究開発能力を強化しました。

さらに2023年5月、エランコはモノクローナル抗体を用いた致死的な犬パルボウイルス疾患の画期的な治療法を発表しました。この一回の静脈内投与で、ワクチン接種の有無にかかわらず、病気の犬や子犬のパルボウイルスによって引き起こされる徴候を治療します。

動物医療向けモノクローナル抗体市場レポートハイライト

  • 動物の種類別では、ペットとしての犬の採用が増加していることと、犬の病気治療を対象とした研究開発が増加していることから、2024年には犬セグメントが圧倒的な売上シェアを占めています。
  • 用途別では、犬のアトピー性皮膚炎の有病率の増加により、皮膚科分野が2024年に51.31%以上の最大市場シェアを占めました。
  • 最終用途別では、動物病院セグメントが2024年に圧倒的な市場シェアを占めたが、これは動物病院に高度な治療施設があるためです。
  • 北米は2024年に約43.775%の最大市場シェアを占めたが、これは同地域に主要市場企業が存在するためです。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/補助市場展望
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
    • 市場機会分析
    • 市場課題分析
  • 業界分析
    • ポーターのファイブフォース分析
    • ペステル
  • 規制の枠組み
  • 製品パイプライン分析
  • 価格分析
  • COVID-19の影響分析

第4章 動物医療向けモノクローナル抗体市場：動物タイプ別推定・動向分析

  • セグメントダッシュボード
  • 動物医療向けモノクローナル抗体市場：動物タイプ別変動分析、2024年および2030年
  • 犬
  • その他

第5章 動物医療向けモノクローナル抗体市場：用途推定・動向分析

  • セグメントダッシュボード
  • 動物医療向けモノクローナル抗体市場：用途変動分析、2024年および2030年
  • 皮膚科市場
  • 痛み
  • その他

第6章 動物医療向けモノクローナル抗体市場：エンドユーザーの推定・動向分析

  • 動物医療向けモノクローナル抗体市場：エンドユーザー変動分析、2024年および2030年
  • 動物病院
  • その他

第7章 動物医療向けモノクローナル抗体市場：地域推定・動向分析

  • 動物医療向けモノクローナル抗体市場：地域変動分析、2024年および2030年
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • スウェーデン
    • デンマーク
    • ノルウェー
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • オーストラリア
    • 韓国
    • タイ
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第8章 競合情勢

  • 市場参入企業の分類
  • 企業の市況分析/ヒープマップ分析
  • 企業プロファイル
    • Zoetis Inc.
    • Boehringer Ingelheim Gmbh
    • Merck &Co., Inc.
    • Elanco
    • Virbac SA
    • Indian Immunologicals Ltd
  • 戦略マッピング
    • 合併と買収
    • パートナーシップとコラボレーション
    • 拡大
    • 製品発売
    • 製品承認
    • その他
  • List of Other Players

第9章 重要なポイント

図表

List of Tables

  • Table 1 List of secondary sources
  • Table 2 Global Monoclonal Antibodies In Veterinary Health Market, by region, 2018 - 2030 (USD Million)
  • Table 3 Global Monoclonal Antibodies In Veterinary Health Market, by application, 2018 - 2030 (USD Million)
  • Table 4 Global Monoclonal Antibodies In Veterinary Health Market, by animal type, 2018 - 2030 (USD Million)
  • Table 5 Global Monoclonal Antibodies In Veterinary Health Market, by end user, 2018 - 2030 (USD Million)
  • Table 6 North America Monoclonal Antibodies In Veterinary Health Market, by country, 2018 - 2030 (USD Million)
  • Table 7 North America Monoclonal Antibodies In Veterinary Health Market, by application, 2018 - 2030 (USD Million)
  • Table 8 North America Monoclonal Antibodies In Veterinary Health Market, by animal type, 2018 - 2030 (USD Million)
  • Table 9 North America Monoclonal Antibodies In Veterinary Health Market, by end user, 2018 - 2030 (USD Million)
  • Table 10 U.S. Monoclonal Antibodies In Veterinary Health Market, by application, 2018 - 2030 (USD Million)
  • Table 11 U.S. Monoclonal Antibodies In Veterinary Health Market, by animal type, 2018 - 2030 (USD Million)
  • Table 12 U.S. Monoclonal Antibodies In Veterinary Health Market, by end user, 2018 - 2030 (USD Million)
  • Table 13 Canada Monoclonal Antibodies In Veterinary Health Market, by application, 2018 - 2030 (USD Million)
  • Table 14 Canada Monoclonal Antibodies In Veterinary Health Market, by animal type, 2018 - 2030 (USD Million)
  • Table 15 Canada Monoclonal Antibodies In Veterinary Health Market, by end user, 2018 - 2030 (USD Million)
  • Table 16 Europe Monoclonal Antibodies In Veterinary Health Market, by country, 2018 - 2030 (USD Million)
  • Table 17 Europe Monoclonal Antibodies In Veterinary Health Market, by application, 2018 - 2030 (USD Million)
  • Table 18 Europe Monoclonal Antibodies In Veterinary Health Market, by animal type, 2018 - 2030 (USD Million)
  • Table 19 Europe Monoclonal Antibodies In Veterinary Health Market, by end user, 2018 - 2030 (USD Million)
  • Table 20 UK Monoclonal Antibodies In Veterinary Health Market, by application, 2018 - 2030 (USD Million)
  • Table 21 UK Monoclonal Antibodies In Veterinary Health Market, by animal type, 2018 - 2030 (USD Million)
  • Table 22 UK Monoclonal Antibodies In Veterinary Health Market, by end user, 2018 - 2030 (USD Million)
  • Table 23 Germany Monoclonal Antibodies In Veterinary Health Market, by application, 2018 - 2030 (USD Million)
  • Table 24 Germany Monoclonal Antibodies In Veterinary Health Market, by animal type, 2018 - 2030 (USD Million)
  • Table 25 Germany Monoclonal Antibodies In Veterinary Health Market, by end user, 2018 - 2030 (USD Million)
  • Table 26 France Monoclonal Antibodies In Veterinary Health Market, by application, 2018 - 2030 (USD Million)
  • Table 27 France Monoclonal Antibodies In Veterinary Health Market, by animal type, 2018 - 2030 (USD Million)
  • Table 28 France Monoclonal Antibodies In Veterinary Health Market, by end user, 2018 - 2030 (USD Million)
  • Table 29 Italy Monoclonal Antibodies In Veterinary Health Market, by application, 2018 - 2030 (USD Million)
  • Table 30 Italy Monoclonal Antibodies In Veterinary Health Market, by animal type, 2018 - 2030 (USD Million)
  • Table 31 Italy Monoclonal Antibodies In Veterinary Health Market, by end user, 2018 - 2030 (USD Million)
  • Table 32 Spain Monoclonal Antibodies In Veterinary Health Market, by application, 2018 - 2030 (USD Million)
  • Table 33 Spain Monoclonal Antibodies In Veterinary Health Market, by animal type, 2018 - 2030 (USD Million)
  • Table 34 Spain Monoclonal Antibodies In Veterinary Health Market, by end user, 2018 - 2030 (USD Million)
  • Table 35 Denmark Monoclonal Antibodies In Veterinary Health Market, by application, 2018 - 2030 (USD Million)
  • Table 36 Denmark Monoclonal Antibodies In Veterinary Health Market, by animal type, 2018 - 2030 (USD Million)
  • Table 37 Denmark Monoclonal Antibodies In Veterinary Health Market, by end user, 2018 - 2030 (USD Million)
  • Table 38 Sweden Monoclonal Antibodies In Veterinary Health Market, by application, 2018 - 2030 (USD Million)
  • Table 39 Sweden Monoclonal Antibodies In Veterinary Health Market, by animal type, 2018 - 2030 (USD Million)
  • Table 40 Sweden Monoclonal Antibodies In Veterinary Health Market, by end user, 2018 - 2030 (USD Million)
  • Table 41 Norway Monoclonal Antibodies In Veterinary Health Market, by application, 2018 - 2030 (USD Million)
  • Table 42 Norway Monoclonal Antibodies In Veterinary Health Market, by animal type, 2018 - 2030 (USD Million)
  • Table 43 Norway Monoclonal Antibodies In Veterinary Health Market, by end user, 2018 - 2030 (USD Million)
  • Table 44 Asia Pacific Monoclonal Antibodies In Veterinary Health Market, by country, 2018 - 2030 (USD Million)
  • Table 45 Asia Pacific Monoclonal Antibodies In Veterinary Health Market, by application, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific Monoclonal Antibodies In Veterinary Health Market, by animal type, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific Monoclonal Antibodies In Veterinary Health Market, by end user, 2018 - 2030 (USD Million)
  • Table 48 Japan Monoclonal Antibodies In Veterinary Health Market, by application, 2018 - 2030 (USD Million)
  • Table 49 Japan Monoclonal Antibodies In Veterinary Health Market, by animal type, 2018 - 2030 (USD Million)
  • Table 50 Japan Monoclonal Antibodies In Veterinary Health Market, by end user, 2018 - 2030 (USD Million)
  • Table 51 China Monoclonal Antibodies In Veterinary Health Market, by application, 2018 - 2030 (USD Million)
  • Table 52 China Monoclonal Antibodies In Veterinary Health Market, by animal type, 2018 - 2030 (USD Million)
  • Table 53 China Monoclonal Antibodies In Veterinary Health Market, by end user, 2018 - 2030 (USD Million)
  • Table 54 India Monoclonal Antibodies In Veterinary Health Market, by application, 2018 - 2030 (USD Million)
  • Table 55 India Monoclonal Antibodies In Veterinary Health Market, by animal type, 2018 - 2030 (USD Million)
  • Table 56 India Monoclonal Antibodies In Veterinary Health Market, by end user, 2018 - 2030 (USD Million)
  • Table 57 South Korea Monoclonal Antibodies In Veterinary Health Market, by application, 2018 - 2030 (USD Million)
  • Table 58 South Korea Monoclonal Antibodies In Veterinary Health Market, by animal type, 2018 - 2030 (USD Million)
  • Table 59 South Korea Monoclonal Antibodies In Veterinary Health Market, by end user, 2018 - 2030 (USD Million)
  • Table 60 Australia Monoclonal Antibodies In Veterinary Health Market, by application, 2018 - 2030 (USD Million)
  • Table 61 Australia Monoclonal Antibodies In Veterinary Health Market, by animal type, 2018 - 2030 (USD Million)
  • Table 62 Australia Monoclonal Antibodies In Veterinary Health Market, by end user, 2018 - 2030 (USD Million)
  • Table 63 Thailand Monoclonal Antibodies In Veterinary Health Market, by application, 2018 - 2030 (USD Million)
  • Table 64 Thailand Monoclonal Antibodies In Veterinary Health Market, by animal type, 2018 - 2030 (USD Million)
  • Table 65 Thailand Monoclonal Antibodies In Veterinary Health Market, by end user, 2018 - 2030 (USD Million)
  • Table 66 Latin America Monoclonal Antibodies In Veterinary Health Market, by country, 2018 - 2030 (USD Million)
  • Table 67 Latin America Monoclonal Antibodies In Veterinary Health Market, by application, 2018 - 2030 (USD Million)
  • Table 68 Latin America Monoclonal Antibodies In Veterinary Health Market, by animal type, 2018 - 2030 (USD Million)
  • Table 69 Latin America Monoclonal Antibodies In Veterinary Health Market, by end user, 2018 - 2030 (USD Million)
  • Table 70 Brazil Monoclonal Antibodies In Veterinary Health Market, by application, 2018 - 2030 (USD Million)
  • Table 71 Brazil Monoclonal Antibodies In Veterinary Health Market, by animal type, 2018 - 2030 (USD Million)
  • Table 72 Brazil Monoclonal Antibodies In Veterinary Health Market, by end user, 2018 - 2030 (USD Million)
  • Table 73 Mexico Monoclonal Antibodies In Veterinary Health Market, by application, 2018 - 2030 (USD Million)
  • Table 74 Mexico Monoclonal Antibodies In Veterinary Health Market, by animal type, 2018 - 2030 (USD Million)
  • Table 75 Mexico Monoclonal Antibodies In Veterinary Health Market, by end user, 2018 - 2030 (USD Million)
  • Table 76 Argentina Monoclonal Antibodies In Veterinary Health Market, by application, 2018 - 2030 (USD Million)
  • Table 77 Argentina Monoclonal Antibodies In Veterinary Health Market, by animal type, 2018 - 2030 (USD Million)
  • Table 78 Argentina Monoclonal Antibodies In Veterinary Health Market, by end user, 2018 - 2030 (USD Million)
  • Table 79 MEA Monoclonal Antibodies In Veterinary Health Market, by country, 2018 - 2030 (USD Million)
  • Table 80 MEA Monoclonal Antibodies In Veterinary Health Market, by application, 2018 - 2030 (USD Million)
  • Table 81 MEA Monoclonal Antibodies In Veterinary Health Market, by animal type, 2018 - 2030 (USD Million)
  • Table 82 MEA Monoclonal Antibodies In Veterinary Health Market, by end user, 2018 - 2030 (USD Million)
  • Table 83 South Africa Monoclonal Antibodies In Veterinary Health Market, by application, 2018 - 2030 (USD Million)
  • Table 84 South Africa Monoclonal Antibodies In Veterinary Health Market, by animal type, 2018 - 2030 (USD Million)
  • Table 85 South Africa Monoclonal Antibodies In Veterinary Health Market, by end user, 2018 - 2030 (USD Million)
  • Table 86 Saudi Arabia Monoclonal Antibodies In Veterinary Health Market, by application, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia Monoclonal Antibodies In Veterinary Health Market, by animal type, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia Monoclonal Antibodies In Veterinary Health Market, by end user, 2018 - 2030 (USD Million)
  • Table 89 UAE Monoclonal Antibodies In Veterinary Health Market, by application, 2018 - 2030 (USD Million)
  • Table 90 UAE Monoclonal Antibodies In Veterinary Health Market, by animal type, 2018 - 2030 (USD Million)
  • Table 91 UAE Monoclonal Antibodies In Veterinary Health Market, by end user, 2018 - 2030 (USD Million)
  • Table 92 Kuwait Monoclonal Antibodies In Veterinary Health Market, by application, 2018 - 2030 (USD Million)
  • Table 93 Kuwait Monoclonal Antibodies In Veterinary Health Market, by animal type, 2018 - 2030 (USD Million)
  • Table 94 Kuwait Monoclonal Antibodies In Veterinary Health Market, by end user, 2018 - 2030 (USD Million)
  • Table 95 Participant's overview
  • Table 96 Financial performance
  • Table 97 Indication/ Services benchmarking
  • Table 98 Strategic Initiatives

List of Figures

  • Fig. 1 Market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 QFD modelling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Commodity Flow Analysis
  • Fig. 9 Monoclonal Antibodies In Veterinary Health Market revenue, 2018-2030 (USD Million)
  • Fig. 10 Monoclonal Antibodies In Veterinary Health Market Snapshot
  • Fig. 11 Monoclonal Antibodies In Veterinary Health Market driver impact
  • Fig. 12 Monoclonal Antibodies In Veterinary Health Market restraint impact
  • Fig. 13 Porter's 5 Forces Analysis
  • Fig. 14 PESTEL Analysis
  • Fig. 15 Monoclonal Antibodies In Veterinary Health Market Animal Type key takeaways (USD Million)
  • Fig. 16 Monoclonal Antibodies In Veterinary Health Market: Animal Type movement analysis
  • Fig. 17 Dogs market, 2018 - 2030 (USD Million)
  • Fig. 18 Other animals market, 2018 - 2030 (USD Million)
  • Fig. 19 Monoclonal Antibodies In Veterinary Health Market Application key takeaways (USD Million)
  • Fig. 20 Monoclonal Antibodies In Veterinary Health Market: Application movement analysis
  • Fig. 21 Dermatology market, 2018 - 2030 (USD Million)
  • Fig. 22 Pain market, 2018 - 2030 (USD Million)
  • Fig. 23 Others market, 2018 - 2030 (USD Million)
  • Fig. 24 Monoclonal Antibodies In Veterinary Health Market End user key takeaways (USD Million)
  • Fig. 25 Monoclonal Antibodies In Veterinary Health Market: End user movement analysis
  • Fig. 26 Veterinary Hospitals & Clinics market, 2018 - 2030 (USD Million)
  • Fig. 27 Other end user market, 2018 - 2030 (USD Million)
  • Fig. 28 Regional market place: Key takeaways
  • Fig. 29 Regional Outlook, 2024 & 2030
  • Fig. 30 North America Monoclonal Antibodies In Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 31 U.S. Monoclonal Antibodies In Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 32 Canada Monoclonal Antibodies In Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 33 Mexico Monoclonal Antibodies In Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 34 Europe Monoclonal Antibodies In Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 35 UK Monoclonal Antibodies In Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 36 Germany Monoclonal Antibodies In Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 37 France Monoclonal Antibodies In Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 38 Italy Monoclonal Antibodies In Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 39 Spain Monoclonal Antibodies In Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 40 Denmark Monoclonal Antibodies In Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 41 Sweden Monoclonal Antibodies In Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 42 Norway Monoclonal Antibodies In Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 43 Asia Pacific Monoclonal Antibodies In Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 44 Japan Monoclonal Antibodies In Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 45 China Monoclonal Antibodies In Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 46 India Monoclonal Antibodies In Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 47 South Korea Monoclonal Antibodies In Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 48 Australia Monoclonal Antibodies In Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 49 Thailand Monoclonal Antibodies In Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 50 Latin America Monoclonal Antibodies In Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 51 Brazil Monoclonal Antibodies In Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 52 Argentina Monoclonal Antibodies In Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 53 MEA Monoclonal Antibodies In Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 54 South Africa Monoclonal Antibodies In Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 55 Saudi Arabia Monoclonal Antibodies In Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 56 UAE Monoclonal Antibodies In Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 57 Kuwait Monoclonal Antibodies In Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 58 Market participant categorization
  • Fig. 59 Heat map analysis
  • Fig. 60 Strategy Mappings
目次
Product Code: GVR-4-68039-973-5

Monoclonal Antibodies In Veterinary Health Market Growth & Trends:

The global monoclonal antibodies in veterinary health market size is estimated to reach USD 3.30 billion by 2030, expanding at a CAGR of 19.1% from 2025 to 2030, according to a new report by Grand View Research, Inc. Increasing pet population coupled with the rising pet expenditure is expected to boost the market growth. Furthermore, the growing prevalence of canine atopic dermatitis will likely drive market growth over the forecast period.

Despite disruption due to the COVID-19 pandemic, the animal health industry witnessed a steady growth of 8% from 2019 to 2020. The economic downturn was relatively less impactful in the animal health industry compared to other markets. The pandemic created a few shifts in business models for veterinary practices and veterinarians. Traditional veterinary practices are expected to generate the most revenue from selling high-margin products like biologics and pharmaceuticals.

The growing incidences of cancer, especially in dogs, are anticipated to provide a growth platform for the market. According to the American Veterinary Medical Association (AVMA), around 1 out of every 4 dogs are expected to show signs of neoplasia at some point in their lives. Neoplasia is a common type of cancer in dogs. Pain management is one of the most important aspects of treating neoplasia in dogs. This can also be treated using the monoclonal antibody treatment.

The market is highly competitive and consists of several major players. With the emergence of immense opportunities in the market, various players in the market are making investments to emerge as leading players. For instance, in October 2021, Zoetis acquired a new development and manufacturing unit in Ireland to improve its production capabilities on veterinary Monoclonal Antibodies (mAbs).

This is anticipated to enhance its veterinary therapeutic biopharmaceuticals portfolio. Moreover, in August 2021, Elanco acquired Kindred Biosciences for approximately USD 444 million. This supported the company's access to the dermatology market, complemented its product pipeline, and enhanced R&D capabilities in biologics and monoclonal antibodies.

In addition, in May 2023, Elanco announced its breakthrough treatment for deadly canine parvovirus diseases using monoclonal antibodies. This single intravenous dose treats the signs caused by parvovirus in sick dogs and puppies regardless of their vaccination status.

Monoclonal Antibodies In Veterinary Health Market Report Highlights:

  • Based on animal type, the dog segment held the dominant revenue share in 2024 owing to the growing adoption of dogs as pets and increasing R&D targeting canine disease treatments
  • Based on the application, the dermatology segment accounted for the largest market share of over 51.31% in 2024, owing to the increasing prevalence of canine atopic dermatitis
  • The veterinary hospital segment accounted for a dominant market share in terms of end-user in 2024, owing to the availability of advanced treatment facilities in veterinary hospitals
  • The North America accounted for the largest market share of around 43.775% in 2024, owing to the presence of major market players in the region

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Research Methodology
    • 1.2.1. Information Procurement
  • 1.3. Information or Data Analysis
  • 1.4. General Methodology
  • 1.5. Research Scope & Assumptions
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
    • 1.7.2. Bottom-Up & Hybrid Model
    • 1.7.3. CAGR Calculation
  • 1.8. List of Secondary Sources

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
    • 3.2.3. Market Opportunity Analysis
    • 3.2.4. Market Challenge Analysis
  • 3.3. Industry Analysis
    • 3.3.1. Porter's
    • 3.3.2. PESTEL
  • 3.4. Regulatory Framework
  • 3.5. Product Pipeline Analysis
  • 3.6. Pricing Analysis
  • 3.7. COVID-19 Impact Analysis

Chapter 4. Monoclonal Antibodies In Veterinary Health Market: Animal Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Monoclonal Antibodies In Veterinary Health Market: Animal Type Movement Analysis, 2024 & 2030 (USD Million)
  • 4.3. Dogs
    • 4.3.1. Dogs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Others
    • 4.4.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Monoclonal Antibodies In Veterinary Health Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Monoclonal Antibodies In Veterinary Health Market: Application Movement Analysis, 2024 & 2030 (USD Million)
  • 5.3. Dermatology Market
    • 5.3.1. Dermatology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Pain
    • 5.4.1. Pain Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Others
    • 5.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Monoclonal Antibodies In Veterinary Health Market: End User Estimates & Trend Analysis

  • 6.1. Monoclonal Antibodies In Veterinary Health Market: End User Movement Analysis, 2024 & 2030 (USD Million)
  • 6.2. Veterinary Hospitals
    • 6.2.1. Veterinary Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3. Others
    • 6.3.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Monoclonal Antibodies In Veterinary Health Market: Regional Estimates & Trend Analysis

  • 7.1. Monoclonal Antibodies In Veterinary Health Market: Regional Movement Analysis, 2024 & 2030
  • 7.2. North America
    • 7.2.1. North America Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. Key Country Dynamics
      • 7.2.2.2. U.S. Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1. Key Country Dynamics
      • 7.2.3.2. Canada Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.2.4. Mexico
      • 7.2.4.1. Key Country Dynamics
      • 7.2.4.2. Mexico Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.3.2. UK
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. UK Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Germany Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.3.4. France
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. France Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.3.5. Italy
      • 7.3.5.1. Key Country Dynamics
      • 7.3.5.2. Italy Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.3.6. Spain
      • 7.3.6.1. Key Country Dynamics
      • 7.3.6.2. Spain Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.3.7. Sweden
      • 7.3.7.1. Key Country Dynamics
      • 7.3.7.2. Sweden Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.3.8. Denmark
      • 7.3.8.1. Key Country Dynamics
      • 7.3.8.2. Denmark Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.3.9. Norway
      • 7.3.9.1. Key Country Dynamics
      • 7.3.9.2. Norway Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.2. China
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. China Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Japan
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Japan Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. India
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. India Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.5. Australia
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Australia Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.6. South Korea
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. South Korea Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.7. Thailand
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Thailand Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Brazil Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Argentina
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Argentina Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Middle East & Africa
    • 7.6.1. Middle East & Africa Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. South Africa
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. South Africa Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. Saudi Arabia
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Saudi Arabia Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. UAE
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. UAE Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. Kuwait
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Kuwait Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
  • 8.2. Company Market Position Analysis/ Heap Map Analysis
  • 8.3. Company Profiles
    • 8.3.1. Zoetis Inc.
      • 8.3.1.1. Participant's Overview
      • 8.3.1.2. Financial Performance
      • 8.3.1.3. Product Benchmarking
      • 8.3.1.4. Strategic Initiatives
    • 8.3.2. Boehringer Ingelheim Gmbh
      • 8.3.2.1. Participant's Overview
      • 8.3.2.2. Financial Performance
      • 8.3.2.3. Product Benchmarking
      • 8.3.2.4. Strategic Initiatives
    • 8.3.3. Merck & Co., Inc.
      • 8.3.3.1. Participant's Overview
      • 8.3.3.2. Financial Performance
      • 8.3.3.3. Product Benchmarking
      • 8.3.3.4. Strategic Initiatives
    • 8.3.4. Elanco
      • 8.3.4.1. Participant's Overview
      • 8.3.4.2. Financial Performance
      • 8.3.4.3. Product Benchmarking
      • 8.3.4.4. Strategic Initiatives
    • 8.3.5. Virbac S.A.
      • 8.3.5.1. Participant's Overview
      • 8.3.5.2. Financial Performance
      • 8.3.5.3. Product Benchmarking
      • 8.3.5.4. Strategic Initiatives
    • 8.3.6. Indian Immunologicals Ltd
      • 8.3.6.1. Participant's Overview
      • 8.3.6.2. Financial Performance
      • 8.3.6.3. Product Benchmarking
      • 8.3.6.4. Strategic Initiatives
  • 8.4. Strategy Mapping
    • 8.4.1. Mergers & Acquisitions
    • 8.4.2. Partnerships & Collaborations
    • 8.4.3. Expansion
    • 8.4.4. Product launch
    • 8.4.5. Product Approval
    • 8.4.6. Others
  • 8.5. List of Other Players

Chapter 9. Key Takeaways